0001387131-21-009808.txt : 20211006 0001387131-21-009808.hdr.sgml : 20211006 20211006170335 ACCESSION NUMBER: 0001387131-21-009808 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211001 FILED AS OF DATE: 20211006 DATE AS OF CHANGE: 20211006 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Desai Meera J. CENTRAL INDEX KEY: 0001886559 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36242 FILM NUMBER: 211310328 MAIL ADDRESS: STREET 1: 1682 EL CAMINO REAL STREET 2: STE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Adamis Pharmaceuticals Corp CENTRAL INDEX KEY: 0000887247 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820429727 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11682 EL CAMINO REAL STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 997-2400 MAIL ADDRESS: STREET 1: 11682 EL CAMINO REAL STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: CELLEGY PHARMACEUTICALS INC DATE OF NAME CHANGE: 19950615 4 1 mdesai-form4_100121.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2021-10-01 0 0000887247 Adamis Pharmaceuticals Corp ADMP 0001886559 Desai Meera J. C/O ADAMIS PHARMACEUTICALS CORPORATION 11682 EL CAMINO REAL, SUITE 300 SAN DIEGO CA 92130 1 0 0 0 Stock Appreciation Right 1.01 2021-10-01 4 A 0 50000 0 A 2028-10-01 Common Stock 50000 50000 D Each Stock Appreciation Right is the economic equivalent of one share of ADMP common stock and can only be settled in cash. The Stock Appreciation Right ("SAR") will vest with respect to 1/6 of the shares subject to the SAR on the six-month anniversary of the date of grant, and thereafter with respect to 1/36 of the shares on each monthly anniversary of the date of grant with all remaining unvested shares subject to the SAR vesting on the thirty-sixth (36th) monthly anniversary of the date of grant. /s/ David C. Benedicto, as Attorney-in-Fact 2021-10-06